Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Nature Medicine

• Publication date

  1999-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/7403PMID 10202929
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biology of Natural Killer Cells

  2008cited by this paper
• CD1d-restricted and TCR-mediated activation of V α14 NKT cells by glycosylceramides

  2000cited by this paper
• The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation.

  1998cited by this paper
• Dendritic cells and the control of immunity

  1998cited by this paper
• Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: implications for anti-cancer and anti-viral therapy.

  1998cited by this paper
• Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes

  1998cited by this paper
• c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities.

  1998cited by this paper
• Absence of B7.1‐CD28/CTLA‐4‐mediated co‐stimulation in human NK cells

  1998cited by this paper
• Follow the leader: NK cell receptors for classical and nonclassical MHC class I.

  1998cited by this paper
• Dendritic cells: unique leukocyte populations which control the primary immune response.

  1997cited by this paper
• Innate immunity: impact on the adaptive immune response.

  1997cited by this paper
• Flt3 ligand induces tumor regression and antitumor immune responses in vivo

  1997cited by this paper
• A New Mechanism of NK Cell Cytotoxicity Activation: The CD40–CD40 Ligand Interaction

  1997cited by this paper
• Dendritic Cells: Unique Leukocyte Populations Which Control the Primary

  1997cited by this paper
• In Vivo Microbial Stimulation Induces Rapid CD40 Ligand–independent Production of Interleukin 12 by Dendritic Cells and their Redistribution to T Cell Areas

  1997cited by this paper
• Maturation Stages of Mouse Dendritic Cells in Growth Factor–dependent Long-Term Cultures

  1997cited by this paper
• CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.

  1997cited by this paper
• Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.

  1997cited by this paper
• Interleukin-12, Dendritic Cells, and the Initiation of Host-protective Mechanisms against Toxoplasma gondii

  1997cited by this paper
• Antitumor activity and immunotherapeutic properties of Flt3-ligand in a murine breast cancer model.

  1997cited by this paper
• Requirement for Vα14 NKT Cells in IL-12-Mediated Rejection of Tumors

  1997cited by this paper
• Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1)

  1996cited by this paper
• Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

  1996cited by this paper
• Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified

  1996cited by this paper
• Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity

  1996cited by this paper
• NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection.

  1996cited by this paper
• Interleukin‐12 is required for interferon‐γ production and lethality in lipopolysaccharide‐induced shock in mice

  1995cited by this paper
• Upregulation of B7 molecules by the Epstein-Barr virus enhances susceptibility to lysis by a human NK-like cell line.

  1995cited by this paper
• Functional role of type I and type II interferons in antiviral defense.

  1994cited by this paper
• Induction of natural killer cell migration by monocyte chemotactic protein−1, −2 and −3

  1994cited by this paper
• RAG-2-deficient blastocyst complementation: an assay of gene function in lymphocyte development.

  1993cited by this paper
• Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population

  1993cited by this paper
• Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

  1992cited by this paper
• Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells

  1992cited by this paper
• Human natural killer cells express VLA-4 and VLA-5, which mediate their adhesion to fibronectin.

  1991cited by this paper
• Tumor antigen presentation by murine epidermal cells.

  1991cited by this paper
• Immunoregulatory role of in vitro differentiated macrophages on human natural killer (NK)-cell activity.

  1990cited by this paper
• Dendritic cells pulsed with protein antigens in vitro can prime antigen- specific, MHC-restricted T cells in situ [published erratum appears in J Exp Med 1990 Oct 1;172(4):1275]

  1990cited by this paper
• Acute injury and regeneration of the mesothelium in response to asbestos fibers.

  1987cited by this paper
• Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts

  1986cited by this paper
• Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy

  1986cited by this paper
• Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo

  1984cited by this paper
• Role of NK cells in tumour growth and metastasis in beige mice

  1980cited by this paper
• Role of natural killer cells in tumor growth and metastasis: C57BL/6 normal and beige mice.

  1980cited by this paper

• Targeting immune microenvironment in cervical cancer: current research and advances

  2025cites this paper
• NKp30: A Key Membrane Molecule in the Fight Against Cancer and Infection

  2025cites this paper
• Natural killer cells: the immune frontline against circulating tumor cells

  2025cites this paper
• Adaptive NK Cells Exhibit Tumor-Specific Immune Memory and Cytotoxicity in Ovarian Cancer.

  2025cites this paper
• Harnessing dendritic cells as immunological bridges to potentiate mRNA cancer vaccines.

  2025cites this paper
• Identification of prognostic genes associated with mitochondria and macrophage polarization in prostate adenocarcinoma based on transcriptome and Mendelian randomization analysis

  2025cites this paper
• Cross-priming in cancer immunology and immunotherapy

  2025cites this paper
• Influenza A virus disruption of dendritic cell-natural killer cell crosstalk impacts activation of naïve helper and cytotoxic T cell subsets

  2025cites this paper
• Dendritic Cell-Based Cancer Vaccines: The Impact of Modulating Innate Lymphoid Cells on Anti-Tumor Efficacy

  2025cites this paper
• Evaluation of cellular immune response and biosafety of SV40 virus-like particle in tumor immunotherapy

  2025cites this paper
• Transcriptional signature of CD56bright NK cells predicts favourable prognosis in bladder cancer

  2025cites this paper
• Tumoricidal potential of binary therapy in lymphoma: Role of DC-NK cross-talk and checkpoint inhibitors.

  2025cites this paper
• Cytokine-Induced Killer Cells: A Unique Platform for Adoptive Cell Immunotherapy after Allogeneic Hematopoietic Stem Cell Transplantation

  2024cites this paper
• Natural Killer cells at the frontline in the fight against cancer

  2024cites this paper
• The future of cellular therapy for the treatment of renal cell carcinoma

  2024cites this paper
• Late-Stage Ovarian Cancer With Systemic Multiple Metastases Shows Marked Shrinkage Using a Combination of Wilms' Tumor Antigen 1 (WT1) Dendritic Cell Vaccine, Natural Killer (NK) Cell Therapy, and Nivolumab

  2024cites this paper
• Insights into the Roles of Natural Killer Cells in Osteoarthritis

  2024cites this paper
• Dendritic cell activation by iron oxide nanoparticles depends on the extracellular environment

  2024cites this paper
• CXCR2-mediated recruitment of adaptive NK cells with NKG2C/HLA-E dependent antigen-specific memory enhances tumor killing in ovarian cancer

  2024cites this paper
• Prostaglandin E2 in the Tumor Microenvironment, a Convoluted Affair Mediated by EP Receptors 2 and 4

  2024cites this paper
• Making a Monkey out of Human Immunodeficiency Virus/Simian Immunodeficiency Virus Pathogenesis: Immune Cell Depletion Experiments as a Tool to Understand the Immune Correlates of Protection and Pathogenicity in HIV Infection

  2024cites this paper
• Emerging strategies for treating autoimmune disease with genetically modified dendritic cells

  2024cites this paper
• Dual Activity of Type III PI3K Kinase Vps34 is Critical for NK Cell Development and Senescence

  2024cites this paper
• The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy

  2023cites this paper
• Perturbomics of tumor-infiltrating NK cells

  2023cites this paper
• Actin cytoskeleton remodeling at the cancer cell side of the immunological synapse: good, bad, or both?

  2023cites this paper
• Antibody conjugates for targeted delivery of Toll-like receptor 9 agonist to the tumor tissue

  2023cites this paper
• NK cells are never alone: crosstalk and communication in tumour microenvironments

  2023cites this paper
• A tumor-immune interaction model with the effect of impulse therapy

  2023cites this paper
• Hacking the Immune Response to Solid Tumors: Harnessing the Anti-Cancer Capacities of Oncolytic Bacteria

  2023cites this paper
• T cells, NK cells, and tumor-associated macrophages in cancer immunotherapy and the current state of the art of drug delivery systems

  2023cites this paper
• Arabinogalactan G1-4A isolated from Tinospora cordifolia induces PKC/mTOR mediated direct activation of natural killer cells and through dendritic cell cross-talk.

  2023cites this paper
• Non-classical HLA-E restricted CMV 15-mer peptides are recognized by adaptive NK cells and induce memory responses

  2023cites this paper
• Cell-based and cell-free immunotherapies for glioblastoma: current status and future directions

  2023cites this paper
• Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities

  2022cites this paper
• 4‐1BB and cytokines trigger human NK, γδ T, and CD8+ T cell proliferation and activation, but are not required for their effector functions

  2022cites this paper
• The Immune and Regenerative Response to Burn Injury

  2022cites this paper
• Dendritic cells Trigger IFN‐γ secretion by NK cells independent of IL‐12 and IL‐18

  2022cites this paper
• γc cytokine-aided crosstalk between dendritic cells and natural killer cells together with doxorubicin induces a healer response in experimental lymphoma by downregulating FOXP3 and programmed cell death protein 1.

  2022cites this paper
• The Latest Approach of Immunotherapy with Endosomal TLR Agonists Improving NK Cell Function: An Overview

  2022cites this paper
• The Role of Myeloid Cells in GBM Immunosuppression

  2022cites this paper
• Recruited and Tissue-Resident Natural Killer Cells in the Lung During Infection and Cancer

  2022cites this paper
• Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control

  2022cites this paper
• Integrative model for discovering linked topics in science and technology

  2022cites this paper
• Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56brightCD16− subset

  2022cites this paper
• Immunomodulatory effects of mixed Lactobacillus plantarum on lipopolysaccharide-induced intestinal injury in mice.

  2022cites this paper
• Nanoparticle mediated targeting of toll-like receptors to treat colorectal cancer.

  2022cites this paper
• NK Cells in Protection from HIV Infection

  2022cites this paper
• NK Cells and ILC1s in Cancer Biology.

  2022cites this paper
• Adoptive cell therapies in thoracic malignancies

  2022cites this paper
• Combination therapy for mCRPC with immune checkpoint inhibitors, ADT and vaccine: A mathematical model

  2022cites this paper
• Current Advances in RNA Therapeutics for Human Diseases

  2022cites this paper
• Natural Killer–Dendritic Cell Interactions in Liver Cancer: Implications for Immunotherapy

  2021cites this paper
• Emerging nanomaterials for cancer immunotherapy

  2021cites this paper
• Quorum sensing governs collective dendritic cell activation in vivo

  2021cites this paper
• NK Cell Anti-Tumor Surveillance in a Myeloid Cell-Shaped Environment

  2021cites this paper
• Simultaneous delivery of immune stimulatory gene and checkpoint blocker via targeted nanoparticles to strengthen anti-tumor immunity

  2021cites this paper
• Reevaluation of NOD/SCID Mice as NK Cell-Deficient Models

  2021cites this paper
• Epigenetic Immune Remodeling of Mesothelioma Cells: A New Strategy to Improve the Efficacy of Immunotherapy

  2021cites this paper
• NK-B cell cross talk induces CXCR5 expression on natural killer cells

  2021cites this paper
• Epicutaneous Administration of 17β-Estradiol Induces Langerhans Cells Depletion

  2021cites this paper
• Functional NK Cell Activation by Ovalbumin Immunization with a Monophosphoryl Lipid A and Poly I:C Combination Adjuvant Promoted Dendritic Cell Maturation

  2021cites this paper
• Gift bags from the sentinel cells of the immune system: The diverse role of dendritic cell‐derived extracellular vesicles

  2021cites this paper
• Antigen-derived peptides directly engage the unfolded-protein sensor IRE1α to curb cross-presentation by dendritic cells

  2021cites this paper
• Characterization and Manipulation of the Crosstalk Between Dendritic and Natural Killer Cells Within the Tumor Microenvironment

  2021cites this paper
• Iron oxide nanoparticle targeted chemo-immunotherapy for triple negative breast cancer.

  2021cites this paper
• Dendritic Cells: Behind the Scenes of T-Cell Infiltration into the Tumor Microenvironment

  2021cites this paper
• Extracellular vesicles as antigen carriers for novel vaccination avenues.

  2021cites this paper
• Next-Generation Immunotherapies to Improve Anticancer Immunity

  2021cites this paper
• Exercise-Induced Changes in Tumor Growth via Tumor Immunity

  2021cites this paper
• Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma

  2020cites this paper
• Human NK cells prime inflammatory DC precursors to induce Tc17 differentiation.

  2020cites this paper
• Dendritic cell maturation by innate lymphocytes: Coordinated stimulation of innate and adaptive immunity

  2020cites this paper
• The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies

  2020cites this paper
• Evidence for Prescribed NK Cell Ly-49 Developmental Pathways in Mice

  2020cites this paper
• Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy

  2020cites this paper
• CR4 Signaling Contributes to a DC-Driven Enhanced Immune Response Against Complement-Opsonized HIV-1

  2020cites this paper
• Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors

  2020cites this paper
• Toll-Like Receptors in Natural Killer Cells and Their Application for Immunotherapy

  2020cites this paper
• Effective Treatments for Bladder Cancer Affecting CXCL9/CXCL10/CXCL11/CXCR3 Axis: A Review

  2020cites this paper
• Combined effect of silver nanoparticles and aluminium chloride, butylparaben or diethylphthalate on the malignancy of MDA-MB-231 breast cancer cells and tumor-specific immune responses of human macrophages and monocyte-derived dendritic cells.

  2020cites this paper
• Distinct Human NK Cell Phenotypes and Functional Responses to Mycobacterium tuberculosis in Adults From TB Endemic and Non-endemic Regions

  2020cites this paper
• IL-18 Responsiveness Defines Limitations in Immune Help for Specialized FcRγ– NK Cells

  2020cites this paper
• Sesamolin promotes cytolysis and migration activity of natural killer cells via dendritic cells

  2020cites this paper
• IntechOpen , the world ’ s leading publisher of Open Access books Built by scientists , for scientists 12

  2019cites this paper
• Cellular Signalling Systems

  2019cites this paper
• The role of ocular dendritic cells in uveitis.

  2019cites this paper
• Chapter 5 Gene-based Interventions for Cancer Immunotherapy

  2019cites this paper
• The Important Role of Dendritic Cell (DC) in iNKT-Mediated Modulation of NK Cell Function in Chlamydia pneumoniae Lung Infection

  2019cites this paper
• Can Dendritic Cell Vaccination Prevent Leukemia Relapse?

  2019cites this paper
• Trial watch: dendritic cell vaccination for cancer immunotherapy

  2019cites this paper
• Regulation of calcium flux by activating and inhibitory receptor crosstalk in NK cells

  2019cites this paper
• Mathematical modeling of the dynamics of the bladder cancer and the immune response applied to a patient: Evolution and short‐term prediction

  2019cites this paper
• NF-κB activation triggers NK-cell stimulation by monocyte-derived dendritic cells

  2019cites this paper
• Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity

  2019cites this paper
• CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy

  2019cites this paper
• Functional Regulation of Ginsenosides on Myeloid Immunosuppressive Cells in the Tumor Microenvironment

  2019cites this paper
• Diselenide-Pemetrexed Assemblies for Combined Cancer Immuno-, Radio-, and Chemotherapies.

  2019cites this paper
• Natural Killer Cells as Key Players of Tumor Progression and Angiogenesis: Old and Novel Tools to Divert Their Pro-Tumor Activities into Potent Anti-Tumor Effects

  2019cites this paper
• Essential role of TNF-α in gamma c cytokine aided crosstalk between dendritic cells and natural killer cells in experimental murine lymphoma.

  2019cites this paper